Sumitomo Dainippon Pharma Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
34,709
33,755
39,560
31,316
53,448
48,627
Depreciation, Depletion & Amortization
26,776
19,226
20,265
12,713
12,887
13,976
Other Funds
7
7
1,076
4
2
6,736
Funds from Operations
65,203
19,532
40,508
20,717
77,458
69,339
Changes in Working Capital
15,260
12,991
11,978
1,574
15,962
20,628
Net Operating Cash Flow
49,943
32,523
52,486
19,143
93,420
48,711
Capital Expenditures
21,556
12,366
9,740
13,459
12,354
Sale of Fixed Assets & Businesses
50
20,014
22
631
10,383
Purchase/Sale of Investments
1,752
14,068
24,585
8,579
6,195
Net Investing Cash Flow
26,208
21,175
12,816
56,129
16,523
Cash Dividends Paid - Total
7,152
7,152
7,152
7,151
7,944
Issuance/Reduction of Debt, Net
20,000
8,563
36,529
15,919
21,664
Net Financing Cash Flow
27,164
15,725
42,605
8,764
29,610
Net Change in Cash
4,520
48,677
14,472
29,969
42,172
Free Cash Flow
39,611
23,861
47,104
11,012
88,291
Net Assets from Acquisitions
-
-
-
84,348
-
Other Sources
-
5
37
32,468
-
Change in Capital Stock
5
3
-
-
-
Exchange Rate Effect
7,949
10,704
8,225
1,747
5,115
Other Uses
6,454
546
2,088
-
8,357
About Sumitomo Dainippon Pharma Co.
View Profile
